{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiho3tuvb4taewgb3gys3ooct5epncvz4ep2q7yotgjxehobp6fqle",
    "uri": "at://did:plc:nzm6xlhdk3myu4xft63gxqp4/app.bsky.feed.post/3mnc3u6ed4yt2"
  },
  "path": "/health/pancreatic-cancer-breakthrough-new-daily-pill-daraxonrasib-doubles-survival-time-for-advanced-patients-11579078",
  "publishedAt": "2026-06-02T06:12:43.000Z",
  "site": "https://www.ndtv.com",
  "tags": [
    "News"
  ],
  "textContent": "A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant...",
  "title": "Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time"
}